Characterization of cardiac fibrosis in older lean vs. obese male ZSF1 rats

被引：0
|
作者：
Mooers, Caitlyn
Pallas, Wrenn
Hannan, Johanna
Garvin, Alexandra
机构：
来源：
PHYSIOLOGY | 2024年 / 39卷
关键词：
D O I：
10.1152/physiol.2024.39.S1.1917
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Renal and metabolic effects of tempol in obese ZSF1 rats-distinct role for superoxide and hydrogen peroxide in diabetic renal injury
    Rafikova, Olga
    Salah, Eman M.
    Tofovic, Stevan P.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (10): : 1434 - 1444
  • [32] Hemodynamic response to behavioral stress in obese vs. lean Zucker rats.
    El-Wazir, YM
    Li, SG
    Randall, DC
    Brown, DR
    FASEB JOURNAL, 1999, 13 (04): : A453 - A453
  • [33] Altered blood volume and vascular reacitvity in lean vs. obese Zucker rats
    Schreihofer, AM
    Hair, CD
    Stepp, DW
    FASEB JOURNAL, 2004, 18 (05): : A1082 - A1082
  • [34] Profile of urinary amino acids and their post-translational modifications (PTM) including advanced glycation end-products (AGEs) of lysine, arginine and cysteine in lean and obese ZSF1 rats
    Svetlana Baskal
    Petra Büttner
    Sarah Werner
    Christian Besler
    Philipp Lurz
    Holger Thiele
    Dimitrios Tsikas
    Amino Acids, 2022, 54 : 643 - 652
  • [35] Profile of urinary amino acids and their post-translational modifications (PTM) including advanced glycation end-products (AGEs) of lysine, arginine and cysteine in lean and obese ZSF1 rats
    Baskal, Svetlana
    Buettner, Petra
    Werner, Sarah
    Besler, Christian
    Lurz, Philipp
    Thiele, Holger
    Tsikas, Dimitrios
    AMINO ACIDS, 2022, 54 (04) : 643 - 652
  • [36] A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats
    Signore, Pierre E.
    Guo, Guangjie
    Wei, Zhihua
    Zhang, Weihua
    Lin, Al
    del Balzo, Ughetta
    PLOS ONE, 2021, 16 (08):
  • [37] Cardiovascular and metabolic consequences of chronic intermittent hypoxia in lean vs. obese zucker rats
    Briancon-Marjollet, A.
    Monneret, D.
    Joyeux-Faure, M.
    Cachot, S.
    Derveaux, T.
    Faure, P.
    Godin-Ribuot, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 48 - 48
  • [38] TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
    Zambad, Shitalkumar P.
    Munshi, Siralee
    Dubey, Amita
    Gupta, Ram
    Busiello, Rosa Anna
    Lanni, Antonia
    Goglia, Fernando
    Gupta, Ramesh C.
    Chauthaiwale, Vijay
    Dutt, Chaitanya
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2011, 4 : 5 - 16
  • [39] The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15
    Stolina, Marina
    Luo, Xin
    Dwyer, Denise
    Han, Chun-Ya
    Chen, Rhonda
    Zhang, Ying
    Xiong, YuMei
    Chen, Yinhong
    Yin, Jun
    Shkumatov, Artem
    Ason, Brandon
    Hale, Clarence
    Veniant, Murielle M.
    PLOS ONE, 2020, 15 (08):
  • [40] Simultaneous Characterization of Metabolic, Cardiac, Vascular and Renal Phenotypes of Lean and Obese SHHF Rats
    Youcef, Gina
    Olivier, Arnaud
    L'Huillier, Clement P. J.
    Labat, Carlos
    Fay, Renaud
    Tabcheh, Lina
    Toupance, Simon
    Rodriguez-Gueant, Rosa-Maria
    Bergerot, Damien
    Jaisser, Frederic
    Lacolley, Patrick
    Zannad, Faiez
    Vallar, Laurent
    Pizard, Anne
    PLOS ONE, 2014, 9 (05):
12345